Chronic lymphocytic leukemia

New England Journal of Medicine

Volumn 333, Issue 16, 1995, Pages 1052-1057

  Rozman, Ciril ^a   Montserrat, Emilio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ALPHA INTERFERON; CHLORAMBUCIL; CLADRIBINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOXORUBICIN; ERYTHROPOIETIN; FLUDARABINE; IMMUNOGLOBULIN; INTERLEUKIN 2; MONOCLONAL ANTIBODY; PENTOSTATIN; PREDNISONE; PURINE DERIVATIVE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; VINCRISTINE;

ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOIMMUNITY; B LYMPHOCYTE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; CYTOPENIA; HEMOLYTIC ANEMIA; HUMAN; HYPOGAMMAGLOBULINEMIA; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOPROLIFERATIVE DISEASE; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

AGED; ANTINEOPLASTIC AGENTS; CHLORAMBUCIL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MIDDLE AGE; PROGNOSIS; SUPPORT, NON-U.S. GOV'T;

EID: 0028822481     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199510193331606     Document Type: Review

References (59)

1. Finch SC, Linet MS Chronic leukaemias. Baillieres Clin Haematol 1992; 5: 27-56
2. Gaidano G, Newcomb EW, Gong JZ, Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia. Am J Pathol 1994; 144: 1312-1319
3. van Krieken JH, McKeithan TW, Raghoebier S, Medeiros LJ, Kluin PM, Raffeld M Chromosomal translocation t(14;19) as indicated by bcl-3 rearrangement is a rare phenomenon in non-Hodgkin's lymphoma and chronic lymphocytic leukemia: a molecular genetic analysis of 176 cases. Leukemia 1990; 4: 811-812
4. Abts H, Jucker M, Diehl V, Tesch H Human chronic lymphocytic leukemia cells regularly express mRNAs of the protooncogenes lck and c-fgr. Leuk Res 1991; 11: 987-997
5. Hawthorn LA, Chapman R, Oscier D, Cowell JK The consistent 13q14 translocation breakpoint seen in chronic B-cell leukaemia (BCLL) involves deletion of the D13S25 locus which lies distal to the retinoblastoma predisposition gene. Oncogene 1993; 8: 1415-1419
6. Gale RP, Caligaris-Cappio F, Dighiero G, Keating M, Montserrat E, Rai K Recent progress in chronic lymphocytic leukemia. Leukemia 1994; 8: 1610-1614
7. Caligaris-Cappio F, Gottardi D, Alfarano A, The nature of the B lymphocyte in B-chronic lymphocytic leukemia. Blood Cells 1993; 19: 601-613
8. Schroeder HW Jr, Dighiero G The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today 1994; 15: 288-294
9. Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC bcl-2 Gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 1993; 82: 1820-1828
10. Hoffbrand AV, Panayiotidis P, Reittie J, Ganeshaguru K Autocrine and paracrine growth loops in chronic lymphocytic leukemia. Semin Hematol 1993; 30: 306-317
11. Matolcsy A, Inghirami G, Knowles DM Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma). Blood 1994; 83: 1363-1372
12. el Rouby S, Thomas A, Costin D, p53 Gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression. Blood 1993; 82: 3452-3459
13. Juliusson G, Gahrton G Cytogenetics in CLL and related disorders. Baillieres Clin Haematol 1993; 6: 821-848
14. Peterson LC, Parsons R, Church S, Ranheim E, Kay NE Karyotypic evolution correlates with disease progression in B-cell chronic lymphocytic leukemia (B-CLL). Prog Proc Am Soc Clin Oncol 1993; 12: 313-313 abstract.
15. Sthoeger ZM, Sthoeger D, Shtalrid M, Sigler E, Geltner D, Berrebi A Mechanism of autoimmune hemolytic anemia in chronic lymphocytic leukemia. Am J Hematol 1993; 43: 259-264
16. Matutes E, Owusu-Ankomah K, Morilla R, The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994; 8: 1640-1645
17. Cheson BD, Bennet JM, Rai KR, Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-Sponsored Working Group. Am J Hematol 1988; 29: 152-163
18. International Workshop on Chronic Lymphocytic Leukemia. Chronic lymphocytic leukemia: recommendations for diagnosis, staging, and response criteria. Ann Intern Med 1989; 110: 236-238
19. Bennet JM, Catovsky D, Daniel MT, Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. J Clin Pathol 1989; 42: 567-584
20. Que TH, Marco JG, Ellis T, Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype, and morphology. Blood 1993; 82: 571-575
21. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219-234
22. Binet JL, Auquier A, Dighiero G, A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981; 48: 198-206
23. Rozman C, Montserrat E, Rodriguez-Fernandez JM, Bone marrow histologic pattern -- the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. Blood 1984; 64: 642-648
24. Rozman C, Montserrat E, Feliu E, Prognosis of chronic lymphocytic leukemia: a multivariate survival analysis of 150 cases. Blood 1982; 59: 1001-1005
25. Montserrat E, Sanchez-Bisono J, Vinolas N, Rozman C Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance. Br J Haematol 1986; 62: 567-575
26. Montserrat E, Rozman C Chronic lymphocytic leukaemia: prognostic factors and natural history. Baillieres Clin Haematol 1993; 6: 849-866
27. Dohner H, Fischer K, Bentz M, p53 Gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood 1995; 85: 1580-1589
28. Robertson LE, Pugh W, O'Brien S, Richter's syndrome: a report on 39 patients. J Clin Oncol 1993; 11: 1985-1989
29. Enno A, Catovsky D, O'Brien M, Cherchi M, Kumaran TO, Galton DA “Protolymphocytoid” transformation of chronic lymphocytic leukaemia. Br J Haematol 1979; 41: 9-18
30. Catovsky D, Fooks J, Richards S, MRC Working Party on Leukaemia in Adults Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. Br J Haematol 1989; 72: 141-149
31. Montserrat E, Vinolas N, Reverter JC, Rozman C Natural history of chronic lymphocytic leukemia: on the progression and prognosis of early clinical stages. Nouv Rev Fr Hematol 1988; 30: 359-361
32. The French Cooperative Group on Chronic Lymphocytic Leukemia. Effects of chlorambucil and therapeutic decision in initial forms of chronic lymphocytic leukemia (stage A): results of a randomized clinical trial on 612 patients. Blood 1990; 75: 1414-1421
33. Catovsky D, Richards S, Fooks J, CLL trials in the United Kingdom. Leuk Lymphoma 1991; 5: Suppl: 105-112
34. Spanish Cooperative Group on CLL. Treatment of chronic lymphocytic leukemia: a preliminary report of Spanish (PETHEMA) trials. Leuk Lymphoma 1991; 5: Suppl: 89-91
35. Montserrat E, Rozman C Chronic lymphocytic leukemia: present status. Ann Oncol 1995; 6: 219-235
36. Wallner J, Gisslinger H, Gisslinger B, MDR1 gene expression in chronic lymphocytic leukemia. Leuk Lymphoma 1994; 13: 333-338
37. Chikkappa G, Pasquale D, Zarrabi MH, Weiler RJ, Divakara M, Tsan MF Cyclosporine and prednisone therapy for pure red cell aplasia in patients with chronic lymphocytic leukemia. Am J Hematol 1992; 41: 5-12
38. Molica S Infections in chronic lymphocytic leukemia: risk factors, and impact on survival, and treatment. Leuk Lymphoma 1994; 13: 203-214
39. Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia. Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia: a randomized, controlled clinical trial. N Engl J Med 1988; 319: 902-907
40. Chapel H, Dicato M, Gamm H, Immunoglobulin replacement in patients with chronic lymphocytic leukaemia: a comparison of two dose regimens. Br J Haematol 1994; 88: 209-212
41. Jurlander J, Geisler CH, Hansen MM Treatment of hypogammaglobulinaemia in chronic lymphocytic leukaemia by low-dose intravenous gammaglobulin. Eur J Haematol 1994; 53: 114-118
42. Hollander AAMJ, Kluin-Nelemans HC, Haak HR, Stern AC, Willemze R, Fibbe WE Correction of neutropenia associated with chronic lymphocytic leukemia following treatment with granulocyte-macrophage colony-stimulating factor. Ann Hematol 1991; 62: 32-34
43. Pangalis GA, Poziopoulos C, Angelopoulou MK, Siakantaris MP, Panayiotidis P Effective treatment of disease-related anaemia in B-chronic lymphocytic leukaemia patients with recombinant human erythropoietin. Br J Haematol 1995; 89: 627-629
44. Keating MJ, O'Brien S, Kantarjian H, Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent. Blood 1993; 81: 2878-2884
45. Hiddemann W, Johnson S, Smith A, Fludarabine versus cyclophosphamide, adriamycin, prednisone (CAP) for the treatment of chronic lymphocytic leukemia: results of a multinational prospective randomized trial. Blood 1993; 82: Suppl 1: 199a-199a abstract.
46. French Cooperative Group on CLL. Comparison of fludarabine (FDB), CAP and ChOP in previously untreated stage B and C chronic lymphocytic leukemia (CLL): first interim results of a randomized clinical trial in 247 patients. Blood 1994; 84: Suppl 1: 461a-461a abstract.
47. Anaissie E, Kontoyiannis DP, Kantarjian H, Elting L, Robertson LE, Keating M Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone. Ann Intern Med 1992; 117: 466-469
48. Saven A, Lemon RH, Kosty M, Beutler E, Piro LD 2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia. J Clin Oncol 1995; 13: 570-574
49. Delannoy A, Martiat P, Gala JL, 2-Chlorodeoxyadenosine (CdA) for patients with previously untreated chronic lymphocytic leukemia (CLL). Leukemia 1995; 9: 1130-1135
50. Ho AD, Thaler J, Stryckmans P, Pentostatin in refractory chronic lymphocytic leukemia: a phase II trial of the European Organization for Research and Treatment of Cancer. J Natl Cancer Inst 1990; 82: 1416-1420
51. Robertson LE, Huh YO, Butler JJ, Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis. Blood 1992; 80: 29-36
52. Lenormand B, Bizet M, Fruchart C, Residual disease in B-cell chronic lymphocytic leukemia patients and prognostic value. Leukemia 1994; 8: 1019-1026
53. Rabinowe SN, Soiffer RJ, Gribben JG, Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia. Blood 1993; 82: 1366-1376
54. Khouri IF, Keating MJ, Vriesendorp HM, Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results. J Clin Oncol 1994; 12: 748-758
55. Michallet M, Archimbaud E, Juliusson G, Autologous transplants in chronic lymphocytic leukemia: report of 18 cases. Bone Marrow Transplant 1995; 15: Suppl 2: S11-S11 abstract.
56. Bartlett-Pandite L, Soiffer R, Gribben JG, Autologous and allogeneic bone marrow transplantation for B-cell CLL: balance between toxicity and efficacy. Blood 1994; 84: Suppl 1: 536a-536a abstract.
57. Zomas A, Mehta J, Powles R, Unusual infections following allogeneic bone marrow transplantation for chronic lymphocytic leukemia. Bone Marrow Transplant 1994; 14: 799-803
58. Montserrat E, Villamor N, Urbano-Ispizua A, Ribera JM, Rozman C Alpha interferon in chronic lymphocytic leukemia. Eur J Cancer 1991; 27: Suppl 4: S74-S77
59. Peng B, Mehta NH, Fernandes H, Chou CC, Raveche E Growth inhibition of malignant CD5+B (B-1) cells by antisense IL-10 oligonucleotide. Leuk Res 1995; 19: 159-167